Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma
| Title: | Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma |
|---|---|
| Authors: | Maxime Fayon; Carolina Martinez-Cingolani; Audrey Abecassis; Nathalie Roders; Elisabeth Nelson; Caroline Choisy; Alexis Talbot; Armand Bensussan; Jean-Paul Fermand; Bertrand Arnulf; Jean-Christophe Bories |
| Source: | Haematologica, Vol 106, Iss 4 (2020) |
| Publisher Information: | Ferrata Storti Foundation |
| Publication Year: | 2020 |
| Collection: | Directory of Open Access Journals: DOAJ Articles |
| Subject Terms: | Diseases of the blood and blood-forming organs; RC633-647.5 |
| Document Type: | article in journal/newspaper |
| Language: | English |
| Relation: | https://haematologica.org/article/view/9809; https://doaj.org/toc/0390-6078; https://doaj.org/toc/1592-8721; https://doaj.org/article/ab64dca534a844b489b55ce6a30ed6df |
| DOI: | 10.3324/haematol.2019.242453 |
| Availability: | https://doi.org/10.3324/haematol.2019.242453; https://doaj.org/article/ab64dca534a844b489b55ce6a30ed6df |
| Accession Number: | edsbas.F64A464A |
| Database: | BASE |